In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation.
Watch the full FDA listening session in the video below.
Related Topics
Action Alert: Urge Congress to Support the Ovarian Cancer IMPACT Act
After months of dedicated advocacy alongside survivors, families, and clinicians, the bipartisan Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing (IMPACT) Act has officially been introduced in Congress. Championed by Senators Elissa Slotkin (D-MI) and Katie Britt (R-AL) in the Senate, and Representatives Rosa DeLauro (D-CT-03) and Don Bacon (R-NE-01) in the House, this bill … Continued
The Overview: September 2026
Dear Friends, Every day, I’m reminded that this community doesn’t wait for change—it builds it, together. That’s true across everything OCRA does, and it’s true of the impact we have made, with your help, through our September fundraising campaign. Because so many of you have stepped forward, we’ve extended our goal to $350,000. Every gift … Continued
OCRA’s International Gynecologic Cancer Conference® Session Recordings Now Available to Watch Free Online
Watch expert sessions on ovarian, endometrial, cervical, and rare gynecologic cancers, and more This September, more than 2,180 people from 65 countries came together for OCRA’s 2026 International Gynecologic Cancer Conference® to learn the latest updates, gain resources for navigating gynecologic cancer, and find support, community, and hope. If you couldn’t join us live, or … Continued